An update on vitamin D and human immunity
暂无分享,去创建一个
[1] A. Konstantinos. Vitamin D and tuberculosis , 2014, The Medical journal of Australia.
[2] J. Powell,et al. Vitamin D and cardiovascular disease. , 2014, Circulation research.
[3] D. Barceló,et al. Liquid chromatography–tandem mass spectrometry , 2013, Analytical and Bioanalytical Chemistry.
[4] J. Stockman. Common genetic determinants of vitamin D insufficiency: a genome-wide association study , 2012 .
[5] D. Eyles,et al. Vitamin D and the brain. , 2011, Best practice & research. Clinical endocrinology & metabolism.
[6] Sneha S. Joshi,et al. 1,25-Dihydroxyvitamin D3 Ameliorates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17A , 2011, Molecular and Cellular Biology.
[7] A. Rudensky,et al. Regulatory T cells and Foxp3 , 2011, Immunological reviews.
[8] C. Wagner,et al. The vitamin D requirement during human lactation: the facts and IOM's ‘utter’ failure , 2011, Public Health Nutrition.
[9] W. Grant. The Institute of Medicine did not find the vitamin D–cancer link because it ignored UV-B dose studies , 2011, Public Health Nutrition.
[10] I. Bhan,et al. Vitamin D–Binding Protein Modifies the Vitamin D–Bone Mineral Density Relationship , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[11] R. Heaney,et al. Why the IOM recommendations for vitamin D are deficient , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[12] J. Geleijnse. Vitamin D and the prevention of hypertension and cardiovascular diseases: a review of the current evidence. , 2011, American journal of hypertension.
[13] A. Avenell,et al. Evidence‐based policy on dietary calcium and vitamin D , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[14] R. Recker,et al. Vitamin D(3) is more potent than vitamin D(2) in humans. , 2011, The Journal of clinical endocrinology and metabolism.
[15] A. Slomski. IOM endorses vitamin D, calcium only for bone health, dispels deficiency claims. , 2011, JAMA.
[16] R. Wilkinson,et al. High-dose vitamin D3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial , 2011, The Lancet.
[17] R. Stockley,et al. Vitamin D-binding protein contributes to COPD by activation of alveolar macrophages , 2011, Thorax.
[18] W. Grant. Is the Institute of Medicine Report on Calcium and Vitamin D Good Science? , 2011, Biological research for nursing.
[19] D. Feldman,et al. Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. , 2011, Annual review of pharmacology and toxicology.
[20] JoAnn E. Manson,et al. The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know , 2010, The Journal of clinical endocrinology and metabolism.
[21] R. Heaney. 25-Hydroxyvitamin D and calcium absorption. , 2011, The American journal of clinical nutrition.
[22] S. Bae,et al. Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis , 2011, Molecular Biology Reports.
[23] B. Musellim,et al. The association between BsmI variant of vitamin D receptor gene and susceptibility to tuberculosis , 2011, Molecular Biology Reports.
[24] J. Adams,et al. T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism , 2010, Proceedings of the National Academy of Sciences.
[25] Jonathan Himmelfarb,et al. Current Opinion in Nephrology and Hypertension , 2010 .
[26] M. Vogeser. Quantification of circulating 25-hydroxyvitamin D by liquid chromatography–tandem mass spectrometry , 2010, The Journal of Steroid Biochemistry and Molecular Biology.
[27] T. Olsson,et al. Confirmation of association between multiple sclerosis and CYP27B1 , 2010, European Journal of Human Genetics.
[28] M. Wheeler,et al. Proficiency testing of 25-Hydroxyvitamin D (25-OHD) assays , 2010, The Journal of Steroid Biochemistry and Molecular Biology.
[29] R. Wilkinson,et al. Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D. , 2010, The Journal of clinical endocrinology and metabolism.
[30] R. Hayes,et al. Circulating 25-Hydroxyvitamin D and Risk of Pancreatic Cancer , 2010, American journal of epidemiology.
[31] J. T. Afshari,et al. Lack of association of vitamin D receptor gene BsmI polymorphisms in patients with systemic lupus erythematosus , 2010, Rheumatology International.
[32] Jian-Huang Wu,et al. Association between FokI polymorphism in vitamin D receptor gene and susceptibility to spinal tuberculosis in Chinese Han population. , 2010, Archives of medical research.
[33] L. Gao,et al. Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[34] M. Mura,et al. 1,25-Dihydroxyvitamin D3 and IL-2 Combine to Inhibit T Cell Production of Inflammatory Cytokines and Promote Development of Regulatory T Cells Expressing CTLA-4 and FoxP31 , 2009, The Journal of Immunology.
[35] P. Glendenning,et al. Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol. , 2009, Bone.
[36] G. Cheng,et al. Divergence of macrophage phagocytic and antimicrobial programs in leprosy. , 2009, Cell host & microbe.
[37] R. Spíšek,et al. Paricalcitol (19-nor-1,25-dihydroxyvitamin D2) and calcitriol (1,25-dihydroxyvitamin D3) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells. , 2009, Clinical immunology.
[38] S. Anderson,et al. Association between Gc genotype and susceptibility to TB is dependent on vitamin D status , 2009, European Respiratory Journal.
[39] Justin A. Spanier,et al. Estrogen Controls Vitamin D3-Mediated Resistance to Experimental Autoimmune Encephalomyelitis by Controlling Vitamin D3 Metabolism and Receptor Expression1 , 2009, The Journal of Immunology.
[40] P. Menheere,et al. Association Study on Two Vitamin D Receptor Gene Polymorphisms and Vitamin D Metabolites in Multiple Sclerosis , 2009, Annals of the New York Academy of Sciences.
[41] Kerry Naunton,et al. Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis , 2009, Journal of Neuroimmunology.
[42] P. Menheere,et al. Vitamin D Status Is Positively Correlated with Regulatory T Cell Function in Patients with Multiple Sclerosis , 2009, PloS one.
[43] BD Beretich,et al. Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis , 2009, Multiple sclerosis.
[44] G. Cheng,et al. Convergence of IL-1β and VDR Activation Pathways in Human TLR2/1-Induced Antimicrobial Responses , 2009, PloS one.
[45] M. Sodemann,et al. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. , 2009, American journal of respiratory and critical care medicine.
[46] G. Martin,et al. Journal of Translational Medicine BioMed Central Review , 2008 .
[47] L. Adorini,et al. Calcitriol Suppresses Antiretinal Autoimmunity through Inhibitory Effects on the Th17 Effector Response 1 , 2009, The Journal of Immunology.
[48] R. Daynes,et al. TLR-Induced Local Metabolism of Vitamin D3 Plays an Important Role in the Diversification of Adaptive Immune Responses1 , 2009, The Journal of Immunology.
[49] A. Gombart,et al. Vitamin D-Directed Rheostatic Regulation of Monocyte Antibacterial Responses1 , 2009, The Journal of Immunology.
[50] D. Rao,et al. Determinants of 25-hydroxyvitamin D levels in African-American and Caucasian male veterans , 2009, Osteoporosis International.
[51] L. Nguyen,et al. Vitamin D Induces Innate Antibacterial Responses in Human Trophoblasts via an Intracrine Pathway1 , 2009, Biology of reproduction.
[52] C. Camargo,et al. Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[53] N. Tandon,et al. Prevalence of vitamin D deficiency and its relationship with thyroid autoimmunity in Asian Indians: a community-based survey , 2009, British Journal of Nutrition.
[54] M. Holick,et al. Vitamin D status: measurement, interpretation, and clinical application. , 2009, Annals of epidemiology.
[55] G. Carter,et al. Use of a common standard improves the performance of liquid chromatography-tandem mass spectrometry methods for serum 25-hydroxyvitamin-D , 2009, Annals of clinical biochemistry.
[57] J. Adams,et al. IL-15 Links TLR2/1-Induced Macrophage Differentiation to the Vitamin D-Dependent Antimicrobial Pathway , 2008, The Journal of Immunology.
[58] S. Anderson,et al. VITAMIN D DEFICIENCY AND INSUFFICIENCY IN CHILDREN WITH TUBERCULOSIS , 2008, The Pediatric infectious disease journal.
[59] M. Haussler,et al. Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. , 2008, Nutrition reviews.
[60] D. Kamen,et al. Vitamin D in systemic lupus erythematosus , 2008, Current opinion in rheumatology.
[61] A. Scillitani,et al. Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. , 2008, The Journal of clinical endocrinology and metabolism.
[62] Andreas Radbruch,et al. 1,25‐dihydroxyvitamin D3 promotes IL‐10 production in human B cells , 2008, European journal of immunology.
[63] L. Adorini,et al. Control of autoimmune diseases by the vitamin D endocrine system , 2008, Nature Clinical Practice Rheumatology.
[64] O. Yoshie,et al. 1,25-Dihydroxyvitamin D3 Induces CCR10 Expression in Terminally Differentiating Human B Cells1 , 2008, The Journal of Immunology.
[65] M. Holick,et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. , 2008, The Journal of clinical endocrinology and metabolism.
[66] A. Clarke,et al. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. , 2008, International journal of epidemiology.
[67] P. Dhawan,et al. Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3). , 2007, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[68] J. Todd,et al. Association of the Vitamin D Metabolism Gene CYP27B1 With Type 1 Diabetes , 2007, Diabetes.
[69] D. Trump,et al. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics , 2007, Nature Reviews Cancer.
[70] P. Lipsky,et al. Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation , 2007, The Journal of Immunology.
[71] Robert J Wilkinson,et al. A single dose of vitamin D enhances immunity to mycobacteria. , 2007, American journal of respiratory and critical care medicine.
[72] J. Söderlund,et al. The antimicrobial peptide LL-37 inhibits HIV-1 replication. , 2007, Current HIV research.
[73] H. Argani,et al. Calcitriol started in the donor, expands the population of CD4+CD25+ T cells in renal transplant recipients. , 2007, Transplantation proceedings.
[74] R. Wilkinson,et al. Vitamin D in the treatment of pulmonary tuberculosis , 2007, The Journal of Steroid Biochemistry and Molecular Biology.
[75] N. Range,et al. Influence of candidate susceptibility genes on tuberculosis in a high endemic region. , 2007, Molecular immunology.
[76] Junliang Pan,et al. DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27 , 2007, Nature Immunology.
[77] Y. Helfrich,et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. , 2007, The Journal of clinical investigation.
[78] A. Ascherio,et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. , 2006, JAMA.
[79] C. Doglioni,et al. Treatment of Experimental Autoimmune Prostatitis in Nonobese Diabetic Mice by the Vitamin D Receptor Agonist Elocalcitol1 , 2006, The Journal of Immunology.
[80] L. Nguyen,et al. Effects of 25-Hydroxyvitamin D3 and 1,25-Dihydroxyvitamin D3 on Cytokine Production by Human Decidual Cells1 , 2006, Biology of reproduction.
[81] S. Romagnani. Regulation of the T cell response , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[82] L. Nyström,et al. Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS) , 2006, Diabetologia.
[83] K. Badenhoop,et al. Protection From Type 1 Diabetes by Vitamin D Receptor Haplotypes , 2006, Annals of the New York Academy of Sciences.
[84] S. Madronich,et al. Epidemic influenza and vitamin D , 2006, Epidemiology and Infection.
[85] J. Aloia,et al. Optimal vitamin D status and serum parathyroid hormone concentrations in African American women. , 2006, The American journal of clinical nutrition.
[86] M. Cantorna,et al. Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. , 2006, Progress in biophysics and molecular biology.
[87] Maureen L. Coleman,et al. Genomic Islands and the Ecology and Evolution of Prochlorococcus , 2006, Science.
[88] C. Rumende,et al. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. , 2006, Acta medica Indonesiana.
[89] G. Sigurdsson,et al. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. , 2005, JAMA.
[90] S. Lewis,et al. Meta-analysis of vitamin D receptor polymorphisms and pulmonary tuberculosis risk. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[91] K. Spach,et al. Vitamin D3 Confers Protection from Autoimmune Encephalomyelitis Only in Female Mice1 , 2005, The Journal of Immunology.
[92] S. Nagpal,et al. Noncalcemic actions of vitamin D receptor ligands. , 2005, Endocrine reviews.
[93] H. Koeffler,et al. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up‐regulated in myeloid cells by 1,25‐dihydroxyvitamin D3 , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[94] H. Wulf,et al. How Finsen's light cured lupus vulgaris , 2005, Photodermatology, photoimmunology & photomedicine.
[95] R. Wilkinson,et al. Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London. , 2005, The Journal of infection.
[96] S. Pearce,et al. A haplotype of the CYP27B1 promoter is associated with autoimmune Addison's disease but not with Graves' disease in a UK population. , 2005, Journal of molecular endocrinology.
[97] S. Harris. Vitamin D in type 1 diabetes prevention. , 2005, The Journal of nutrition.
[98] R. Lea,et al. VARIATION IN THE VITAMIN D RECEPTOR GENE IS ASSOCIATED WITH MULTIPLE SCLEROSIS IN AN AUSTRALIAN POPULATION , 2005, Journal of neurogenetics.
[99] S. Akira,et al. Toll-like receptors in innate immunity. , 2004, International immunology.
[100] P. Vestergaard,et al. Plasma concentrations of 25-Hydroxy-Vitamin D and 1,25-Dihydroxy-Vitamin D are Related to the Phenotype of Gc (Vitamin D-Binding Protein): A Cross-sectional Study on 595 Early Postmenopausal Women , 2005, Calcified Tissue International.
[101] John H. White,et al. Cutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression , 2004, The Journal of Immunology.
[102] A. Uitterlinden,et al. Genetics and biology of vitamin D receptor polymorphisms. , 2004, Gene.
[103] Tsuyoshi Kayo,et al. Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis. , 2004, Physiological genomics.
[104] J. Constans,et al. Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP) , 1993, Human Genetics.
[105] R. Grad. Cod and the consumptive: a brief history of cod-liver oil in the treatment of pulmonary tuberculosis. , 2004, Pharmacy in history.
[106] M. Uskoković,et al. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. , 2004, Journal of cellular biochemistry.
[107] R. Andreesen,et al. Regulation of 25-hydroxyvitamin D3-1α-hydroxylase and production of 1α,25-dihydroxyvitamin D3 by human dendritic cells , 2003 .
[108] Aristides G. Eliopoulos,et al. Differential Regulation of Vitamin D Receptor and Its Ligand in Human Monocyte-Derived Dendritic Cells1 , 2003, The Journal of Immunology.
[109] Cecilia A. Hale,et al. Calcium Absorption Varies within the Reference Range for Serum 25-Hydroxyvitamin D , 2003, Journal of the American College of Nutrition.
[110] R. Andreesen,et al. Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha,25-dihydroxyvitamin D3 by human dendritic cells. , 2003, Blood.
[111] David F. Richards,et al. In Vitro Generation of Interleukin 10–producing Regulatory CD4+ T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)– and Th2-inducing Cytokines , 2002, The Journal of experimental medicine.
[112] H. Ohmori,et al. HUMAN NEUTROPHILS EXPRESS MESSENGER RNA OF VITAMIN D RECEPTOR AND RESPOND TO 1α,25-DIHYDROXYVITAMIN D3 , 2002, Immunopharmacology and immunotoxicology.
[113] M. Tremblay,et al. Targeted ablation of the 25-hydroxyvitamin D 1α-hydroxylase enzyme: Evidence for skeletal, reproductive, and immune dysfunction , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[114] R. Kumar,et al. Dendritic cell modulation by 1α,25 dihydroxyvitamin D3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[115] P. Vestergaard,et al. Mean serum concentration of vitamin D-binding protein (Gc globulin) is related to the Gc phenotype in women. , 2001, Clinical chemistry.
[116] M. Taniyama,et al. Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population. , 2000, The Journal of clinical endocrinology and metabolism.
[117] L. Adorini,et al. 1α,25-Dihydroxyvitamin D3 Inhibits Differentiation, Maturation, Activation, and Survival of Dendritic Cells Leading to Impaired Alloreactive T Cell Activation , 2000, The Journal of Immunology.
[118] R. Wilkinson,et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study , 2000, The Lancet.
[119] J. Cowland,et al. An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma. , 1997, Journal of immunological methods.
[120] Y. Taketani,et al. A Vitamin D Receptor Gene Polymorphism in the Translation Initiation Codon: Effect on Protein Activity and Relation to Bone Mineral Density in Japanese Women , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[121] P. Galan,et al. Prevalence of Vitamin D Insufficiency in an Adult Normal Population , 1997, Osteoporosis International.
[122] Kenneth M. Murphy,et al. Functional diversity of helper T lymphocytes , 1996, Nature.
[123] H. DeLuca,et al. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[124] H. Spiegelberg,et al. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. , 1995, The Journal of nutrition.
[125] N. Yamamoto,et al. Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[126] S. A. Westwood,et al. The phenotypic frequencies of group specific component and alpha-2-HS-glycoprotein in three ethnic groups. The use of these proteins as racial markers in forensic biology. , 1987, Forensic science international.
[127] D. Katz,et al. Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol. , 1987, Immunology.
[128] G. Rook,et al. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. , 1986, Immunology.
[129] J. Adams,et al. 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. , 1985, Journal of immunology.
[130] H. Koeffler,et al. gamma-Interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages. , 1985, Biochemical and biophysical research communications.
[131] J. Adams,et al. 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. , 1984, The Journal of clinical investigation.
[132] S. Manolagas,et al. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. , 1983, Science.
[133] T. Oppé,et al. Vitamin D deficiency. , 1979, British medical journal.
[134] G. Herrera. Vitamin D in massive doses as an adjuvant to the sulfones in the treatment of tuberculoid leprosy. , 1949, International journal of Leprosy.
[135] H. Chaglassian. Calciferol Treatment of Leprosy1: Preliminary Report of Two Cases , 1948 .
[136] H. Chaglassian. Calciferol treatment of leprosy; preliminary report of two cases. , 1948, The Journal of investigative dermatology.